Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a highly anticipated oral pill.
The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...
Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...
HealthDay on MSN4d
Ozempic, Wegovy Could Help Ease Knee Arthritis PainThe GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.People who r ...
Investor's Business Daily on MSN5d
Amgen 'Laser-Focused' On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOAmgen is focusing deeply on its efforts to treat obesity, the CFO said Wednesday. But Amgen stock dipped a fraction in late trades.
News Medical on MSN1d
Weight loss drug semaglutide may offer relief for knee arthritis painSemaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.
Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...
Weight loss drugs like semaglutide may reduce knee pain from osteoarthritis offering a promising alternative to knee ...
A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback